Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2018

2018-12-31
Price :
Published : Dec-2018
No. of Pages : 105
order by fax Inquire before Buying request discount
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 25
In Progress Trials by Phase 26
Clinical Trials by Trial Status 27
Clinical Trials by End Point Status 29
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Central Retinal Vein Occlusion Therapeutics Clinical Trials 34
Prominent Drugs 36
Clinical Trial Profile Snapshots 37
Appendix 103
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 104
Contact Us 105
Source 105

List of Tables
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region, 2018* 7
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 17
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 22
Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase, 2018* 25
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 26
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 31
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36

List of Figures
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Central Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2018* 16
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Central Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Central Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2018* 21
Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Central Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase (%), 2018* 25
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 26
Central Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2018* 27
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2018* 29
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 30
Central Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 31
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 32
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 34
Central Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 36
GlobalData Methodology 104
Filed in: Pharmaceutical, Therapeutics
Publisher : GlobalData